BSX · News · 20260820N

Market Demand Trends

BOSTON SCIENTIFIC CORP · 2026-08-20 · Importance 40 · Surprise 56

The global cardiovascular devices market is projected to grow from $72.4 billion in 2025 to $101.6 billion by 2030, representing approximately 40% expansion. Growth is expected to be driven by an aging population, increased disease prevalence, minimally invasive procedures, and remote monitoring. Leadless pacemakers, pulsed field ablation, and AI-enabled cardiac monitoring are identified as key growth areas, with Boston Scientific, Abbott, and Medtronic among the dominant participants.

Key facts

• The global cardiovascular devices market is projected to grow from $72.4 billion in 2025 to $101.6 billion by 2030. source
• Asahi Life Asset Management CO. LTD. bought 10,155 shares of Boston Scientific valued at approximately $433,000. source
• Edmond DE Rothschild Holding S.A. acquired 875,810 shares of Boston Scientific valued at approximately $37.38 million. source
• Edmond DE Rothschild Holding S.A.'s acquisition made it a 0.06% owner of Boston Scientific. source
• Boston Scientific shares fell 5.08% to $49.37 on Thursday. source
• The GlobeNewswire item lists Boston Scientific as one of the major players dominating the global cardiovascular devices market alongside Abbott and Medtronic. source